Trial Profile
A Phase 1, Multiple-dose, Evaluator-blind, Randomized, Parallel Group Study Evaluating the Safety and Cutaneous Tolerability of SB204 (NVN1000 Gel) in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Acne vulgaris
- Focus Adverse reactions
- Sponsors Novan Inc
- 10 Jan 2014 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 07 May 2013 New trial record